NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 56 filers reported holding NEUROCRINE BIOSCIENCES INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $295,000 | -91.7% | 235,000 | -91.5% | 0.00% | -98.6% |
| Q1 2020 | $3,547,000 | +15.4% | 2,757,000 | +37.8% | 0.14% | +150.0% |
| Q4 2019 | $3,073,000 | +348.0% | 2,000,000 | +300.0% | 0.06% | +194.7% |
| Q3 2019 | $686,000 | -89.3% | 500,000 | -90.7% | 0.02% | -95.9% |
| Q4 2018 | $6,419,000 | -41.5% | 5,366,000 | -16.5% | 0.46% | +17.0% |
| Q3 2018 | $10,968,000 | +18.1% | 6,425,000 | 0.0% | 0.39% | -30.7% |
| Q2 2018 | $9,289,000 | – | 6,425,000 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| III Capital Management | 12,500,000 | $17,262,000 | 3.12% |
| CSS LLC/IL | 24,395,000 | $33,616,000 | 1.59% |
| Mint Tower Capital Management B.V. | 9,000,000 | $12,407,000 | 1.46% |
| Context Partners Fund, L.P. | 3,000,000 | $4,125,000 | 0.90% |
| Context Capital Management, LLC | 3,000,000 | $4,125,000 | 0.90% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,258,000 | $5,971,000 | 0.71% |
| SSI INVESTMENT MANAGEMENT LLC | 5,888,000 | $8,100,000 | 0.70% |
| Aequim Alternative Investments LP | 3,000,000 | $4,155,000 | 0.55% |
| WOLVERINE ASSET MANAGEMENT LLC | 32,181,000 | $44,437,000 | 0.40% |
| TWO SIGMA SECURITIES, LLC | 13,000,000 | $17,875,000 | 0.36% |